Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Thyroid cancer, genetic variations, mobile phones linked in study
Radiation from mobile phones is associated with higher rates of thyroid cancer among people with…
Designer probiotic treatment for cancer immunotherapy
Columbia biomedical engineers have designed a novel probiotic strain that after a single dose can…
Vapers show chemical changes in their genome linked to cancer
Biologically important changes in DNA seen in smokers are also being found in people who…
Expert Review: Care of Cancer Survivors by Kim Hobbs
Care of Cancer Survivors: What works? Plenary session by Kim Hobbs, Clinical Specialist Social Worker, Department of Gynaecological Cancer, Westmead Hospital. COSA ASM…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.